MML Investors Services
FOLD

MML Investors Services’s Amicus Therapeutics FOLD Stock Holding History

MML Investors Services’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,252
Closed -$102K – 2596
2024
Q2 		$102K Sell
10,252
-268
-3% -$2.75K ﹤0.01% 2417
2024
Q1 		$124K Buy
+10,520
New +$135K ﹤0.01% 2407
2023
Q1 		– Sell
-10,179
Closed -$124K – 2150
2022
Q4 		$124K Buy
+10,179
New +$115K ﹤0.01% 2080

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

MML Investors Services's FOLD Position: Q3 2024 in Review

MML Investors Services sold out of Amicus Therapeutics (FOLD) in Q3 2024, closing a stake of 10,252 shares — an estimated $102K sold.

MML Investors Services first reported a position in FOLD in Q4 2022 and held it in 3 quarters. The position peaked at $124K in Q1 2024. 293 funds tracked by Wall St. Rank hold FOLD as of Q3 2024.

  • MML Investors Services reported no remaining Amicus Therapeutics position as of Q3 2024 after selling out during the quarter.
  • MML Investors Services sold 10,252 Amicus Therapeutics shares in Q3 2024, an estimated $102K.
  • MML Investors Services first reported a position in Amicus Therapeutics in Q4 2022 and held it in 3 quarters.
  • MML Investors Services's Amicus Therapeutics position peaked at $124K in Q1 2024.
  • 293 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2024.

Based on MML Investors Services's 13F filing for Q3 2024, filed 15 Nov 2024.